Cutler Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,800
| Closed | -$5K | – | 5488 |
|
|
2022
Q3 | $5K | Buy |
19,800
+13,800
| +230% | +$222K | ﹤0.01% | 3728 |
|
|
2022
Q2 | $5K | Sell |
6,000
-10,000
| -63% | -$160K | ﹤0.01% | 3791 |
|
|
2022
Q1 | $35K | Buy |
16,000
+15,800
| +7,900% | +$247K | ﹤0.01% | 2570 |
|
|
2021
Q4 | $1K | Buy |
+200
| New | +$3.37K | ﹤0.01% | 5237 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$1K | – | 6582 |
|
|
2021
Q2 | $1K | Buy |
+200
| New | +$3.96K | ﹤0.01% | 5503 |
|
|
2020
Q4 | – | Sell |
-1,200
| Closed | -$4K | – | 5678 |
|
|
2020
Q3 | $4K | Buy |
+1,200
| New | +$55.1K | ﹤0.01% | 3744 |
|
|
2020
Q2 | – | Sell |
-900
| Closed | -$3K | – | 5048 |
|
|
2020
Q1 | $3K | Sell |
900
-1,900
| -68% | -$171K | ﹤0.01% | 3389 |
|
|
2019
Q4 | $95K | Sell |
2,800
-5,600
| -67% | -$501K | 0.01% | 1232 |
|
|
2019
Q3 | $43K | Buy |
8,400
+7,000
| +500% | +$470K | ﹤0.01% | 1663 |
|
|
2019
Q2 | $18K | Sell |
1,400
-12,800
| -90% | -$1.15M | ﹤0.01% | 2305 |
|
|
2019
Q1 | $105K | Buy |
14,200
+2,200
| +18% | +$240K | 0.01% | 984 |
|
|
2018
Q4 | $98K | Buy |
12,000
+3,600
| +43% | +$373K | 0.01% | 1050 |
|
|
2018
Q3 | $273K | Buy |
8,400
+5,200
| +163% | +$550K | 0.02% | 701 |
|
|
2018
Q2 | $50K | Buy |
3,200
+2,900
| +967% | +$212K | ﹤0.01% | 1613 |
|
|
2018
Q1 | $1K | Sell |
300
-5,000
| -94% | -$301K | ﹤0.01% | 4233 |
|
|
2017
Q4 | $4K | Sell |
5,300
-48,900
| -90% | -$3.08M | ﹤0.01% | 3865 |
|
|
2017
Q3 | $90K | Buy |
54,200
+26,500
| +96% | +$2.85M | ﹤0.01% | 1754 |
|
|
2017
Q2 | $87K | Sell |
27,700
-12,700
| -31% | -$1.47M | ﹤0.01% | 1979 |
|
|
2017
Q1 | $172K | Sell |
40,400
-69,300
| -63% | -$8.09M | 0.01% | 1303 |
|
|
2016
Q4 | $274K | Buy |
109,700
+56,900
| +108% | +$6.78M | 0.01% | 1080 |
|
|
2016
Q3 | $276K | Sell |
52,800
-33,000
| -38% | -$5.2M | 0.01% | 972 |
|
|
2016
Q2 | $390K | Buy |
85,800
+7,200
| +9% | +$1.05M | 0.02% | 719 |
|
|
2016
Q1 | $825K | Buy |
78,600
+27,300
| +53% | +$3.22M | 0.05% | 321 |
|
|
2015
Q4 | $323K | Buy |
+51,300
| New | +$8.68M | 0.02% | 845 |
|
Cutler Group's ICPT Position: Q4 2023 in Review
Cutler Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 17,800 shares — an estimated $330K sold.
Cutler Group first reported a position in ICPT in Q4 2015 and held it in 30 quarters. The position peaked at $2.49M in Q4 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Cutler Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Cutler Group sold 17,800 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $330K.
- Cutler Group first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 30 quarters.
- Cutler Group's Intercept Pharmaceuticals, Inc. position peaked at $2.49M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.